Literature DB >> 3416355

Analysis of the role of the transcription factor ATF in the assembly of a functional preinitiation complex.

T W Hai1, M Horikoshi, R G Roeder, M R Green.   

Abstract

In the accompanying paper (Horikoshi et al., 1988) the interaction between ATF and the general transcription initiation factors was analyzed by DNAase I footprinting experiments. Here, we use transcription assays to investigate the role of ATF in the assembly of a functional preinitiation complex. Addition of an oligonucleotide containing an ATF binding site inhibits E4 transcription by sequestering ATF. However, following preincubation of the E4 promoter in the nuclear extract, transcription is refractory to inhibition by the ATF oligonucleotide. Formation of this oligonucleotide-refractory complex occurs at an early stage in the overall transcription initiation reaction and is dependent upon ATF and the general transcription factors RNA polymerase II, TFIIB, and TFIID. This latter result suggests that the assembly and maintenance of a functional preinitiation complex involves cooperative interactions among the various transcription factors. The general transcription factor TFIIE, although required for transcriptional activity, is not involved in the assembly of an ATF oligonucleotide-refractory complex. Our results support the possibility that ATF may be required only transiently for assembly of a functional preinitiation complex.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3416355     DOI: 10.1016/0092-8674(88)90119-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  62 in total

1.  Roles for non-TATA core promoter sequences in transcription and factor binding.

Authors:  B S Wolner; J D Gralla
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Distinct cAMP response element-binding protein (CREB) domains stimulate different steps in a concerted mechanism of transcription activation.

Authors:  J Kim; J Lu; P G Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

3.  In vitro analysis of a transcription termination site for RNA polymerase II.

Authors:  D K Wiest; D K Hawley
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

4.  Copper and the ACE1 regulatory protein reversibly induce yeast metallothionein gene transcription in a mouse extract.

Authors:  V C Culotta; T Hsu; S Hu; P Fürst; D Hamer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  gadd153/Chop10, a potential target gene of the transcriptional repressor ATF3.

Authors:  C D Wolfgang; B P Chen; J L Martindale; N J Holbrook; T Hai
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

6.  A bipartite DNA binding domain composed of direct repeats in the TATA box binding factor TFIID.

Authors:  T Yamamoto; M Horikoshi; J Wang; S Hasegawa; P A Weil; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

7.  Comparison of two host cell range variants of feline immunodeficiency virus.

Authors:  T R Phillips; R L Talbott; C Lamont; S Muir; K Lovelace; J H Elder
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

8.  Activation of yeast polymerase II transcription by herpesvirus VP16 and GAL4 derivatives in vitro.

Authors:  D I Chasman; J Leatherwood; M Carey; M Ptashne; R D Kornberg
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

9.  Dissection of the functional architecture of a plant defense gene promoter using a homologous in vitro transcription initiation system.

Authors:  J A Arias; R A Dixon; C J Lamb
Journal:  Plant Cell       Date:  1993-04       Impact factor: 11.277

10.  Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. isolate.

Authors:  T Miyazawa; M Fukasawa; A Hasegawa; N Maki; K Ikuta; E Takahashi; M Hayami; T Mikami
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.